2018CCR | Huiyi Huiying Grand released "AI full-cycle management cloud platform", leading AI into 2.0 era

On November 8, 2018, the Chinese Radiology Academic Conference 2018 co-sponsored by the Chinese Medical Association Radiology Branch and the Chinese Medical Association Imaging Technology Branch and the 25th National Radiological Academic Conference of the Chinese Medical Association and the Second Chinese Medical Association Sixteen national academic conferences on medical imaging technology were officially held at the Beijing National Convention Center. This academic annual meeting is not only the academic annual meeting of the two chapters, but also the academic annual meeting of more than 20 professional groups of the two branches. Nearly 10,000 members of the radiological industry attended the event, which is unprecedented.

After receiving the joint capital injection of Intel Capital and Core Kinetics Investment, Huiyi Huiying has once again received wide attention from the industry. On November 8, 2018, at the China Radiology Academic Conference 2018 (CCR2018) held by the Beijing National Convention Center, Huiyi Huiying held a conference on “Artificial Intelligence Full Cycle Health Management Cloud Platform” and released “Breast Cancer”. Artificial Intelligence Full Cycle Health Management Platform and "AORTIST2.0 Aortic Artificial Intelligence Cloud Platform".

Professor Jin Zhengyu, Chairman of the 15th Committee of the Chinese Medical Association Radiology Branch, accompanied the organizing committee to visit the Huihui Huiying booth to guide the work, and had a cordial exchange with Dr. Chai Xiangfei, the founder of Huiyi Huiying.

As a newcomer to the medical AI industry, Huiyi Huiying has received great support and help from the China Medical Imaging AI Industry, Education and Research Innovation Alliance. It invites the top experts and scholars from the Alliance to come to the conference to witness the continuous efforts of Huiyi Huiying. And grow up.

Full chain medical AI solution to finally solve the problem of doctors and patients

The development of image AI depends on the cooperation of enterprises, hospitals and relevant government departments. China Medical Imaging AI Industry, Education and Research Innovation Alliance, through the effective integration of industry resources, establish an industry upstream and downstream resource sharing mechanism, in the technical standards, database establishment, application scenario design and other aspects, to help the application of image AI enterprises It has accelerated the technological innovation and commercial landing of image AI enterprises. As the chairman of the China Medical Imaging AI Industry, Education and Research Innovation Alliance, Professor Liu Shiyuan has been committed to promoting the development of the image AI industry.

Director Liu said, "I have always hoped that the products of Image AI can be applied to the clinic as soon as possible, and we can solve our pain points as soon as possible. The reason why we set up the China Medical Imaging AI Industry-University Research Innovation Alliance is to connect medical imaging AI. The upstream and downstream to promote the healthy and rapid development of the industry."

Director Liu pointed out that "the products and concepts of Huiyi Huiying AI full-cycle health management are very good. At present, the image AI has the following problems: AI light solves the single point problem, and can not solve all the problems of medical imaging; The problem does not solve all the problems of medicine. Therefore, only the full-chain image AI and the full-chain medical AI solution can finally solve the doctor's problem, solve the patient's problem, and solve the problem of expensive medical treatment in China."

Finally, Chairman Liu expressed his congratulations on the release of Huiyi Huiying's new products, and he is eager to see that Huiyi Huiying's new products can bring more value in clinical applications. President Liu expects that there will be more outstanding innovative companies like Huihui Huiying in the field of Chinese imaging AI, which will enable the vast number of doctors to enjoy the transformation and convenience brought by artificial intelligence.

Multi-party cross-border cooperation, let medical AI truly land and maintain vitality

With the joint efforts of the entire industry, artificial intelligence technology has continuously made breakthroughs, and the integration of production, research and research of image AI has further deepened. As a leading imaging AI company, Huiyi Huiying is at the forefront of technology research and development and commercial landing. Currently, it has access to more than 800 hospitals and is the first to launch the “Artificial Intelligence Full Cycle Health Management Cloud Platform” covering the whole process of diagnosis and treatment. .

Chai Xiangfei, founder and CEO of Huiyi Huiying, pointed out that in order to promote the development of image AI, it is necessary to integrate the image AI enterprises, hospitals and academic institutions across the border, in order to bring the new technology of artificial intelligence to life and vitality.

Through various efforts, Huiyi Huiying has launched two artificial intelligence products: “AORTIST2.0 Aortic Artificial Intelligence Cloud Platform”, which has realized the diagnosis and treatment of aortic diseases from the recognition of the fracture to the selection of the stent and the follow-up of the prognosis. Full-cycle coverage; another “breast cancer artificial intelligence full-cycle health management platform”, dedicated to the whole cycle of breast cancer diagnosis and treatment, from mammography screening to nuclear magnetic diagnosis, to pathological diagnosis, pathology Etc., the diagnosis of the disease can be quantified and objective.

Compared with the medical imaging AI1.0 product which only conducts disease screening and auxiliary diagnosis, the biggest feature of the 2.0 product launched by Huiyi Huiying is the deep integration of AI and medical in three aspects: value fusion, data Integration, process integration.

By recommending personalized treatment decision-making programs and optimizing prognosis, artificial intelligence can create greater value for doctors and patients; through the fusion of multimodal data such as CT and MRI, image data, clinical data, pathological data, genetic data, etc. The fusion of type data creates a full image data link; the image AI product seamlessly integrates with the doctor's diagnosis and treatment process, bringing efficiency to the doctor without adding additional work load.

After obtaining the joint capital injection of Intel Capital and Core Kinetics Investment, Huiyi Huiying became the first medical artificial intelligence enterprise invested by the two investment companies in China, further accelerating the pace of technology research and development and product innovation.

Guo Na, co-founder of Huiyi Huiying, believes that the application of multimodal image data and the full cycle coverage of disease diagnosis and treatment are the development trend of the industry. In the future, more diseases will realize the AI ​​application of the whole process. Human-computer collaboration will become the norm for doctors. By then, the supply level of medical services in China will be greatly improved, and the problem of expensive medical treatment will be solved.

Water SYSTEM

Water System,Water Supply System,Feed Water System,Boiler Feed System

JIANGSU NEW FIRE FIGHTING TECHNOLOGY CO.,LTD , https://www.ffo2cylinder.com